11/22/24 09:00 | 11/21/24 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | P | 24 | 0.6000 | 0 | 40 | 26 | 195 | D | | | | | | | | | | | | | | |
5/28/24 09:11 | 5/24/24 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | P | 11 | 1.05 | 0 | 10 | 7 | 155 | D | | | | | | | | | | | | | | |
2/12/24 21:27 | 2/11/24 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 31 | 28 | 145 | D | | | | | | | | | | | | | | |
2/14/23 16:15 | 2/11/23 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 31 | 33 | 126 | D | | | | | | | | | | | | | | |
6/30/22 17:57 | 6/30/22 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 15 | 17 | 108 | D | | | | | | | | | | | | | | |
4/4/22 16:05 | 3/31/22 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 15 | 19 | 98 | D | | | | | | | | | | | | | | |
4/4/22 16:05 | 3/31/22 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | P.d | 10 | 1.53 | 0 | 6 | 7 | 98 | D | | | | | | | | | | | | | | |
3/28/22 19:22 | 3/25/22 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | P | 7 | 1.38 | 0 | 5 | 7 | 81 | D | | | | | | | | | | | | | | |
1/3/22 16:25 | 12/31/21 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 15 | 26 | 76 | D | | | | | | | | | | | | | | |
10/12/21 16:27 | 9/30/21 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 15 | 31 | 66 | D | | | | | | | | | | | | | | |
6/30/21 18:42 | 6/28/21 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.dm | 252 | 0.7976 | 0 | 315 | | 56 | D | | | | | | | | | | | | | | |
6/30/21 18:42 | 6/28/21 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | S.d | -1,292 | 2.87 | 0 | -450 | -89 | 56 | D | | | | | | | | | | | | | | |
4/1/21 20:00 | 3/31/21 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 36 | 2.35 | 0 | 15 | 9 | 196 | D | | | | | | | | | | | | | | |
12/31/20 17:00 | 12/31/20 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 27 | 1.76 | 0 | 15 | 9 | 186 | D | | | | | | | | | | | | | | |
9/30/20 17:00 | 9/30/20 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 14 | 0.9366 | 0 | 15 | 10 | 175 | D | | | | | | | | | | | | | | |
7/2/20 17:05 | 6/30/20 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 13 | 0.8700 | 0 | 15 | 10 | 165 | D | | | | | | | | | | | | | | |
3/31/20 20:00 | 3/31/20 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 13 | 0.8281 | 0 | 15 | 11 | 155 | D | | | | | | | | | | | | | | |
12/31/19 17:00 | 12/31/19 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 15 | 12 | 145 | D | | | | | | | | | | | | | | |
10/1/19 17:00 | 9/30/19 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 15 | 13 | 135 | D | | | | | | | | | | | | | | |
9/19/19 17:00 | 9/17/19 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 62 | 98 | 125 | D | | | | | | | | | | | | | | |
8/15/19 08:39 | 8/13/19 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | P | 10 | 1.01 | 0 | 10 | 13 | 85 | D | | | | | | | | | | | | | | |
1/3/19 20:35 | 1/1/19 | BTX | Biotime Inc | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 100 | | 59 | D | | | | | | | | | | | | | | |
10/25/17 08:12 | 10/23/17 | ATMS | Artemis Therapeutics, Inc. | DE | Chem | Chem | Miscellaneous Chemical Produc | Culley Brian M | NY | O | CEO | P.d | 0 | 0.00 | 0 | 25 | New | 25 | D | | | | | | | | | | | | | | |
3/15/12 16:25 | 3/14/12 | ANX | Adventrx Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Culley Brian M | CA | DO | CEO,Dir | P | 12 | 0.5904 | 0 | 21 | 146 | 35 | D | -89 | -71 | -35 | -3 | -13 | -17 | -9 | -2 | | | | | | |
3/14/12 16:30 | 3/13/12 | ANX | Adventrx Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Culley Brian M | CA | DO | CEO,Dir | P | 8 | 0.5817 | 0 | 14 | New | 14 | D | -89 | -71 | -35 | -3 | -13 | -17 | -9 | -2 | | | | | | |
6/3/11 17:01 | 6/2/11 | ANX | Adventrx Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Culley Brian M | CA | O | CEO | S | -12 | 2.44 | 1 | -5 | -100 | 0 | D | -18 | 11 | 27 | 16 | 4 | -6 | 5 | -2 | -2 | -2 | 22 | -54 | -75 | |
5/27/10 16:10 | 5/27/10 | ANX | Adventrx Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Culley Brian M | CA | O | CEO | P | 9 | 1.89 | 2 | 5 | New | 5 | D | -83 | -43 | -17 | -75 | -72 | -19 | -18 | -2 | 16 | 15 | -11 | -4 | 4 | 29 |